Astera Labs (NASDAQ:ALAB) General Counsel Sells $231,659.88 in Stock

Astera Labs, Inc. (NASDAQ:ALAB) General Counsel Philip Mazzara sold 796 shares of the business’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $291.03, for a total value of $231,659.88. Following the sale, the general counsel directly owned 103,343 shares in the company, valued at $30,075,913.29. The trade was a 0.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Philip Mazzara also recently made the following trade(s):

• On Monday, May 18th, Philip Mazzara sold 14,076 shares of Astera Labs stock. The shares were sold at an average price of $231.78, for a total value of $3,262,535.28.
• On Wednesday, April 1st, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $107.77, for a total value of $1,077,700.00.
• On Monday, March 2nd, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $117.47, for a total value of $1,174,700.00.

Astera Labs Price Performance

Shares of ALAB traded up $11.84 during mid-day trading on Tuesday, reaching $318.72. 8,097,769 shares of the company’s stock traded hands, compared to its average volume of 5,548,043. The stock has a market cap of $54.63 billion, a P/E ratio of 215.35, a P/E/G ratio of 4.06 and a beta of 3.35. The stock’s 50-day moving average is $174.13 and its two-hundred day moving average is $160.46. Astera Labs, Inc. has a 12 month low of $84.78 and a 12 month high of $321.99.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company’s quarterly revenue was up 93.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts have recently commented on ALAB shares. Loop Capital assumed coverage on Astera Labs in a research note on Thursday, March 5th. They set a “buy” rating and a $250.00 target price on the stock. JPMorgan Chase & Co. boosted their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday. Needham & Company LLC boosted their price target on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Finally, Stifel Nicolaus boosted their price target on Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $233.75.

Institutional Trading of Astera Labs

A number of hedge funds have recently bought and sold shares of the stock. Glenmede Trust Co. NA lifted its holdings in Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after buying an additional 51 shares during the period. Verus Capital Partners LLC lifted its holdings in Astera Labs by 16.4% during the first quarter. Verus Capital Partners LLC now owns 3,849 shares of the company’s stock worth $422,000 after buying an additional 541 shares during the period. Liontrust Investment Partners LLP lifted its holdings in Astera Labs by 98.7% during the first quarter. Liontrust Investment Partners LLP now owns 105,270 shares of the company’s stock worth $11,538,000 after buying an additional 52,284 shares during the period. SOA Wealth Advisors LLC. purchased a new stake in Astera Labs during the first quarter worth $49,000. Finally, E20 Capital Ltd purchased a new stake in Astera Labs during the first quarter worth $33,310,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.